Sara Kurdi

Jan 12, 2025 | analyticalsciencejournals.onlinelibrary.wiley.com | Muhammad Khan |John Walsh |Sara Kurdi |Sandeep Mishra

Graphical Abstract The cover image is based on the article Sorafenib alters interstitial proton and sodium levels in the tumor microenvironment: a 1H/23Na spectroscopic imaging study by Fahmeed Hyder et al., https://doi.org/10.1002/nbm.5319.

Jan 6, 2025 | analyticalsciencejournals.onlinelibrary.wiley.com | Muhammad Khan |John Walsh |Sandeep Mishra |Sara Kurdi

Conflicts of Interest F.H. is the founder of InnovaCyclics LLC. He has an equity interest in of InnovaCyclics LLC, which is a biotechnology company creating next-generation MRI contrast agents. The other authors declare no conflicts of interest.